| 注册
首页|期刊导航|器官移植|间充质干细胞来源的外泌体在胰岛移植中的作用研究现状及应用前景

间充质干细胞来源的外泌体在胰岛移植中的作用研究现状及应用前景

李睿 王殿相 梁兆伟 韩冰 廉皓

器官移植2025,Vol.16Issue(1):163-168,6.
器官移植2025,Vol.16Issue(1):163-168,6.DOI:10.12464/j.issn.1674-7445.2024194

间充质干细胞来源的外泌体在胰岛移植中的作用研究现状及应用前景

Current research status and application prospects of mesenchymal stem cell-derived exosomes in islet transplantation

李睿 1王殿相 1梁兆伟 1韩冰 1廉皓1

作者信息

  • 1. 024000 内蒙古赤峰,赤峰市肿瘤医院肿瘤外二科
  • 折叠

摘要

Abstract

Type 1 diabetes mellitus is a chronic autoimmune disease caused by the destruction of pancreatic islet β cells.Pancreatic islet transplantation provides a treatment method for patients with type 1 diabetes mellitus to restore endogenous insulin secretion.However,some problems limit the widespread application of islet transplantation,such as the shortage of donors and post-transplantation rejection damage.Mesenchymal stem cell-derived exosome(MSC-Exo)has become a potential tool for islet transplantation therapy due to their immunomodulatory and tissue repair capabilities.MSC-Exo shows great promise for application,because of low immunogenicity,easily being stored and transported,and the potential as drug delivery vehicles.However,challenges such as preparation,purification,standardization and safety verification need to be overcome before converting MSC-Exo into clinical practice.Therefore,this article reviews the application and potential advantages of MSC-Exo in islet transplantation,aiming to providing more effective and safer treatment options for patients with type 1 diabetes mellitus.

关键词

1型糖尿病/胰岛移植/间充质干细胞/外泌体/炎症反应/血管重建/胰岛再生/药物递送

Key words

Type 1 diabetes mellitus/Islet transplantation/Mesenchymal stem cell/Exosome/Inflammatory response/Vascular reconstruction/Islet regeneration/Drug delivery

分类

医药卫生

引用本文复制引用

李睿,王殿相,梁兆伟,韩冰,廉皓..间充质干细胞来源的外泌体在胰岛移植中的作用研究现状及应用前景[J].器官移植,2025,16(1):163-168,6.

基金项目

内蒙古自治区自然科学基金(2022MS08042) (2022MS08042)

器官移植

OA北大核心

1674-7445

访问量0
|
下载量0
段落导航相关论文